Aimei Health Technology Co., Ltd.

Aimfox Acquisition Corp, trading on Nasdaq under the ticker AFJK, is a blank check company that completed its initial public offering in 2022 with a stated focus on the healthcare and health technology sector, particularly targeting opportunities across Asia-Pacific markets. The SPAC filed an 8-K with the Securities and Exchange Commission on June 20, 2024, in connection with its business combination with Aimei Health Technology Co., Ltd., a health technology company. The filing reflects the SPAC's active combination stage as it works through the transaction process. For complete filing history, sponsor details, and real-time status updates on AFJK and hundreds of other SPACs, sign up for full data access at SpacDesk.